30 June 2026
Latham Advises on RQ Bio’s US$115 Million Series A Financing
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matthew Bush Lead | Latham & Watkins LLP | Partner | Not stated | San Diego |
| Samantha Peacock | Latham & Watkins LLP | Counsel | Not stated | London |
| Louie Gray | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Lydia Torne | Latham & Watkins LLP | Partner | healthcare and life sciences | London |
| Arun Mohan | Latham & Watkins LLP | Associate | healthcare and life sciences | Not stated |
| Karl Mah | Latham & Watkins LLP | Partner | tax | London |
| Allegra Benitah | Latham & Watkins LLP | Associate | tax | Not stated |
| Sarah Gadd | Latham & Watkins LLP | Partner | employment | London |
| Venice Ma | Latham & Watkins LLP | Associate | employment | Not stated |
| Dal Lim | Latham & Watkins LLP | Associate | data and technology | London |
7 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 115m (US$115 million)
- What the figure measures
- Issue size
- Client
- Frazier Life Sciences, EQT Life Sciences, Monograph, and ForbionInvestor
- Counterparties
- RQ Bio (Issuer)